Embroidery in South San Francisco
Pharmaceutical industry in South San Francisco
Pharmaceutical research in South San Francisco
Technology management in South San Francisco
Search results
-
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. We have built our product candidate portfolio through internal discovery and the in-licensing of novel cance…
-
Titan Pharmaceuticals, Inc. (AMEX: TTP) is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize novel technologies that…
-
KAI Pharmaceuticals is a biology-based, product-driven biopharmaceutical company developing a new class of therapeutics that selectively target enzymes within the protein kinase C (PKC) family, with an initial focus in acute cardiovascular disease, angiogenesis, and pain.
-
Overview Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer.
-
Proteases are naturally occurring protein-degrading enzymes that regulate a wide variety of biological processes. Catalyst is harnessing the power of these enzymes as bio-pharmaceuticals by redirecting them to degrade specific proteins that promote disease. Catalyst calls these engineered protease …
-
Novacea, Inc.
(650) 228-1800601 Gateway Boulevard Suite 800 San Francisco, 94080 South San FranciscoWe are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have three clinical-stage oncology product candidates. Our lead product candidate, DN-101, is in a Phase 3 clinical trial for the treatment of androge…
-
Our strategy is to focus both on higher-volume business in the emerging economies of the world, together with the high-value novel medicines in the Western market.
-